Benefit of chemotherapy in stage III nasopharyngeal carcinoma: Analysis of the surveillance, epidemiology, and end results database

Benefit of chemotherapy in stage III nasopharyngeal carcinoma: Analysis of the surveillance, epidemiology, and end results database

Objectives: Chemoradiotherapy is the standard treatment for locoregionally advanced nasopharyngeal carcinoma (NPC). We aimed to reveal factors associated with chemotherapy use and evaluate chemotherapy's benefit in patients with stage III NPC stratified by lymph node status. Patients and method...

Full description

Bibliographic Details
Main Authors: Hu, D.-F (Author), Li, M.-Y (Author), Li, W.-Z (Author), Shen, E.-D (Author), Xiang, Y.-Q (Author), Xiang, Z.-F (Author), Xiong, H.-C (Author), Zhang, Z.-C (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2021
Subjects:
adult
aged
all cause mortality
Article
cancer chemotherapy
cancer mortality
cancer radiotherapy
cancer registry
cancer staging
chemoradiotherapy
Chemoradiotherapy
Chemotherapy
clinical assessment
clinical evaluation
cohort analysis
comparative study
controlled study
data base
Databases, Factual
disease association
disease surveillance
epidemiological data
factual database
female
follow up
Head and neck cancer
human
Humans
lymph node
Lymph node
major clinical study
male
Nasopharyngeal carcinoma
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms
nasopharynx carcinoma
nasopharynx tumor
Neoplasm Staging
outcome assessment
priority journal
propensity score
Retrospective Studies
retrospective study
risk assessment
risk factor
SEER database
SEER Program
selection bias
Survival
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items